CAMPUS CAMPUS NSE
Company Profile ↓Company Overview
CAMPUS (CAMPUS) is a publicly traded company listed on NSE with a market capitalization of ₹6,948.27 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.6%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 64.7%.
Net profit has compounded at 19.3% per year over the last five years.
Revenue has grown at a 133.6% CAGR over the past five years.
Operating margin of 40.0% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.26.
Recent Developments
- Mar 2026 Revenue of ₹1,774.12 Cr (+11.4% YoY); net profit ₹150.09 Cr.
- Trailing 12 Months Year-on-year growth — revenue +11.4%, earnings +23.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 133.6%, profit CAGR 19.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 133.61% |
| 1 Year: | 11.37% |
Compounded Profit Growth
| 5 Years: | 19.34% |
| 1 Year: | 23.86% |
Stock Price Performance
| 1 Year: | -20.84% |
| 6 Months: | -9.83% |
| 3 Months: | -8.25% |
| 1 Month: | -2.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.37 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 64.7%.
- Compounding revenue at 133.6% over 5 years.
- Profit CAGR of 19.3% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 57.3.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2021 | Jun 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 275.00 Cr | 135.00 Cr | 434.00 Cr | 352.00 Cr | 338.00 Cr | 405.71 Cr | 343.27 Cr | 386.61 Cr | 588.61 Cr | 455.63 Cr |
| Cost of Revenue | - | - | - | - | - | 195.88 Cr | 155.79 Cr | 180.42 Cr | 278.92 Cr | 221.18 Cr |
| Gross Profit | - | - | - | - | - | 209.83 Cr | 187.48 Cr | 206.19 Cr | 309.69 Cr | 234.45 Cr |
| Operating Expenses | 210.00 Cr | 120.00 Cr | 341.00 Cr | 274.00 Cr | 276.00 Cr | 53.25 Cr | 52.27 Cr | 55.37 Cr | 59.22 Cr | 60.89 Cr |
| Operating Income | 54.00 Cr | 4.00 Cr | 79.00 Cr | 63.00 Cr | 47.00 Cr | 156.58 Cr | 135.21 Cr | 150.82 Cr | 250.47 Cr | 173.56 Cr |
| EBITDA | 65.00 Cr | 15.00 Cr | 93.00 Cr | 78.00 Cr | 62.00 Cr | 76.74 Cr | 55.41 Cr | 54.33 Cr | 115.76 Cr | 88.51 Cr |
| Interest Expense | 4.00 Cr | 4.00 Cr | 5.00 Cr | 6.00 Cr | 6.00 Cr | 6.36 Cr | 4.91 Cr | 6.19 Cr | 7.30 Cr | 5.86 Cr |
| Pretax Income | 50.00 Cr | 1.00 Cr | 75.00 Cr | 57.00 Cr | 42.00 Cr | 47.61 Cr | 30.38 Cr | 26.95 Cr | 86.06 Cr | 58.78 Cr |
| Tax Provision | 40.00 Cr | -1.51 Cr | 20.25 Cr | 17.67 Cr | 13.44 Cr | 12.58 Cr | 8.18 Cr | 6.88 Cr | 22.38 Cr | 14.64 Cr |
| Net Income | 10.00 Cr | 2.00 Cr | 55.00 Cr | 40.00 Cr | 29.00 Cr | 35.03 Cr | 22.20 Cr | 20.07 Cr | 63.68 Cr | 44.14 Cr |
| Diluted EPS | 0.66 | 0.13 | 1.80 | 1.30 | 0.94 | 1.15 | 0.72 | 0.66 | 2.07 | 1.44 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.00 Cr | 508.00 Cr | 595.00 Cr | 732.00 Cr | 711.00 Cr | - | 1,484.25 Cr | 1,448.29 Cr | 1,592.96 Cr | 1,774.12 Cr |
| Cost of Revenue | - | - | - | - | - | - | 751.98 Cr | 695.46 Cr | 767.26 Cr | 836.31 Cr |
| Gross Profit | - | - | - | - | - | - | 732.27 Cr | 752.83 Cr | 825.70 Cr | 937.81 Cr |
| Operating Expenses | 3.00 Cr | 431.00 Cr | 495.00 Cr | 596.00 Cr | 595.00 Cr | - | 549.65 Cr | 613.40 Cr | 194.45 Cr | 228.47 Cr |
| Operating Income | -1.00 Cr | 41.00 Cr | 86.00 Cr | 113.00 Cr | 83.00 Cr | - | 182.62 Cr | 139.43 Cr | 631.25 Cr | 709.34 Cr |
| EBITDA | -1.00 Cr | 77.00 Cr | 100.00 Cr | 136.00 Cr | 116.00 Cr | - | 256.07 Cr | 215.34 Cr | 258.22 Cr | 314.73 Cr |
| Interest Expense | 0 | 21.00 Cr | 21.00 Cr | 17.00 Cr | 17.00 Cr | - | 28.43 Cr | 23.20 Cr | 18.79 Cr | 24.26 Cr |
| Pretax Income | -1.00 Cr | 20.00 Cr | 66.00 Cr | 99.00 Cr | 70.00 Cr | - | 156.60 Cr | 120.03 Cr | 163.94 Cr | 202.17 Cr |
| Tax Provision | -3.00 L | 12.60 Cr | 27.72 Cr | 36.63 Cr | 43.40 Cr | - | 39.48 Cr | 30.59 Cr | 42.76 Cr | 52.08 Cr |
| Net Income | -1.00 Cr | 7.00 Cr | 39.00 Cr | 62.00 Cr | 27.00 Cr | - | 117.12 Cr | 89.44 Cr | 121.18 Cr | 150.09 Cr |
| Diluted EPS | -145.00 | 741.01 | 3,947.58 | 4.06 | 1.77 | 3.57 | 3.84 | 2.93 | 3.97 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 516.00 Cr | 606.00 Cr | 506.00 Cr | 722.00 Cr | 689.00 Cr | - | 1,175.92 Cr | 1,096.58 Cr | 1,305.17 Cr | 1,467.19 Cr |
| Current Assets | - | - | - | - | - | - | 748.41 Cr | 663.24 Cr | 719.69 Cr | 879.34 Cr |
| Cash & Equivalents | - | - | - | - | - | - | 23.99 Cr | 21.50 Cr | 17.44 Cr | 3.96 Cr |
| Inventory | - | - | - | - | - | - | 448.97 Cr | 396.27 Cr | 379.81 Cr | 449.45 Cr |
| Receivables | - | - | - | - | - | - | 176.65 Cr | 118.26 Cr | 148.01 Cr | 152.75 Cr |
| Total Liabilities | - | - | - | - | - | - | 623.80 Cr | 444.92 Cr | 548.66 Cr | 560.94 Cr |
| Current Liabilities | - | - | - | - | - | - | 455.24 Cr | 276.30 Cr | 328.73 Cr | 371.48 Cr |
| Long Term Debt | - | - | - | - | - | 45.17 Cr | 25.66 Cr | 18.90 Cr | 0 | - |
| Total Debt | 347.00 Cr | 174.00 Cr | 199.00 Cr | 276.00 Cr | 177.00 Cr | - | 335.00 Cr | 177.76 Cr | 232.27 Cr | 236.16 Cr |
| Total Equity | -92.00 L | 298.10 Cr | 202.10 Cr | 285.00 Cr | 313.00 Cr | - | 552.12 Cr | 651.66 Cr | 756.51 Cr | 906.25 Cr |
| Shares Outstanding | - | - | - | - | - | - | 30.47 Cr | 30.53 Cr | 30.54 Cr | 30.56 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 100.00 Cr | -38.00 Cr | 54.00 Cr | 99.00 Cr | 124.00 Cr | - | 126.47 Cr | 264.47 Cr | 235.21 Cr | 134.77 Cr |
| Investing Cash Flow | -291.00 Cr | -47.00 Cr | -29.00 Cr | -155.00 Cr | -9.00 Cr | - | -69.68 Cr | -74.49 Cr | -154.58 Cr | -54.73 Cr |
| Financing Cash Flow | 193.00 Cr | 84.00 Cr | -26.00 Cr | 69.00 Cr | -129.00 Cr | - | -33.15 Cr | -192.47 Cr | -84.69 Cr | -93.52 Cr |
| Capital Expenditure | 0 | -43.00 Cr | -28.00 Cr | -109.00 Cr | -55.00 Cr | - | -68.68 Cr | -45.30 Cr | -59.18 Cr | -90.27 Cr |
| Free Cash Flow | 100.00 Cr | -81.00 Cr | 26.00 Cr | -10.00 Cr | 69.00 Cr | - | 57.79 Cr | 219.17 Cr | 176.03 Cr | 44.50 Cr |
| Net Change in Cash | 2.00 Cr | -1.00 Cr | 0 | 14.00 Cr | -14.00 Cr | - | 23.64 Cr | -2.49 Cr | -4.06 Cr | -13.48 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | 49.3% | 52.0% | 51.8% | 52.9% |
| Operating Margin % | -50.0% | 8.1% | 14.5% | 15.4% | 11.7% | - | 12.3% | 9.6% | 39.6% | 40.0% |
| Net Margin % | -50.0% | 1.4% | 6.6% | 8.5% | 3.8% | - | 7.9% | 6.2% | 7.6% | 8.5% |
| ROE % | 108.7% | 2.3% | 19.3% | 21.8% | 8.6% | - | 21.2% | 13.7% | 16.0% | 16.6% |
| ROCE % | - | - | - | - | - | - | 25.3% | 17.0% | 64.6% | 64.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CAMPUS
Campus Activewear Ltd (BOM:543523) Q4 2026 Earnings Call Highlights: Strong Online Growth and ...
Campus Activewear Ltd (BOM:543523) reports robust revenue growth driven by online sales and unveils a successful brand refresh amidst inflationary challenges.
Campus Activewear Ltd (BOM:543523) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
Campus Activewear Ltd (BOM:543523) reports a robust 14.3% revenue increase, driven by strategic campaigns and product innovation, despite industry headwinds.
CAMPUS — Frequently Asked Questions
What is the current share price of CAMPUS?
As of 2026-07-15 09:52 IST, CAMPUS trades at ₹227.37 on NSE. Its 52-week range is ₹218.85 to ₹298.47.
What is the market capitalisation of CAMPUS?
CAMPUS has a market capitalisation of ₹6,948.27 Cr on NSE.
What is the P/E ratio of CAMPUS?
CAMPUS trades at a trailing price-to-earnings (P/E) ratio of 57.27. Its price-to-book (P/B) ratio is 7.74.
What is the return on equity (ROE) of CAMPUS?
CAMPUS has a return on equity (ROE) of 16.56%. Its return on capital employed (ROCE) is 64.74%.
Is CAMPUS a good stock to buy?
This page provides a data-driven analysis of CAMPUS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.